Centro de Investigación Biomédica en Red CIBER

CIBER (Centro de Investigación Biomédica en Red) Analysis

Name: Centro de Investigación Biomédica en Red CIBER Slogan: Consorcio Centro de Investigación Biomédica en Red CIBER, del Instituto de Salud Carlos III. Description: Centro de Investigación Biomédica en Red de Bioingeniería, Biomateriales y Nanomedicina (CIBER-BBN) is a consortium that brings together leading Spanish research groups from universities, hospitals, and other technological centers. It is focused on translational research and aims to transfer its findings to the industry. Currently, CIBER-BBN consists of 47 research groups, selected for their scientific excellence, distributed across Spain, forming a multidisciplinary group of experts. CIBER-BBN is one of the nine CIBER consortia in Spain, established by the Instituto de Salud Carlos III to promote excellence in biomedical research and build a critical mass of researchers in the fields of biomedicine, health sciences, and related areas. Founded: 2006 Industries: Biopharma, Biotechnology Headquarter: Spain Last Investment: No publicly available information. Last Investment Investors: Not disclosed.

CIBER-BBN, established in 2006 in Spain, is a leading consortium in biomedical research, focusing on bioengineering, biomaterials, and nanomedicine. With 47 research groups renowned for their scientific excellence, CIBER-BBN aims to drive translational research and facilitate the transfer of outcomes to the industry. As one of the nine CIBER consortia in Spain, it has been instrumental in promoting excellence in biomedicine and health sciences. The organization's commitment to advancing biomedical research makes it a potential investment opportunity in the biopharma and biotechnology sectors. However, due to the lack of publicly available information on its last investment, further details on investment opportunities and potential investors are currently unavailable.